Rebound Effect Not Observed With Multiple Sclerosis Therapy Ozanimod
Single-Center Study Provides Support for Natalizumab Use in Pregnant Women With Multiple Sclerosis
CMSC Poster Gives Demographic Insights for Phase 3 PERSEUS Study of Tolebrutinib
CMSC Live: 2025 Annual Meeting Day 1